Treatment Information

Back

Lung Cancer treatment details. Chemotherapy.

University of Ulsan College of Medicine, Seoul, Korea.

Survival: monthsCountry:Korea
Toxiciy Grade:3City/State/Province:Seoul
Treatments:ChemotherapyHospital:University of Ulsan College of Medicine
Drugs:Journal:Link
Date:Dec 2011

Description:

Patients:
This phase II study involved 14 patients with advanced or metastatic non-small-cell lung cancer who had received previous treatments. The median patient age was 59 years and 57.1% were male.

Treatment:
Patients were treated with the chemotherapy agents S-1 and either irinotecan or docetaxel.

Toxicities:
The most severe toxicities were grade 3 neutropenia, diarrhea, and nausea/vomiting.

Results:
The median overall survival time was 5.6 months.

Correspondence: Dr. Dae Ho Lee; email: [email protected]



Back